ATI RN
Physical Exam Cardiovascular System
1. A client on a beta blocker has a heart rate of 52 bpm. What is the nurse’s priority action?
- A. Hold the beta blocker and notify the healthcare provider.
- B. Administer the beta blocker as ordered.
- C. Increase the dose of the beta blocker.
- D. Continue to monitor the client and reassess in 30 minutes.
Correct answer: A
Rationale: The correct answer is to hold the beta blocker and notify the healthcare provider. A heart rate of 52 bpm is low, and beta blockers can further decrease the heart rate, potentially causing harm. Therefore, withholding the medication and promptly informing the healthcare provider is crucial for further assessment and possible adjustment of the treatment plan. Administering the beta blocker as ordered (Choice B) can exacerbate the bradycardia. Increasing the dose of the beta blocker (Choice C) would further suppress the heart rate. Continuing to monitor the client and reassessing in 30 minutes (Choice D) might delay necessary interventions and increase the risk of complications in a client with a heart rate of 52 bpm.
2. What is the accumulation of fatty deposits along the walls of arteries, leading to reduced blood flow?
- A. Atherosclerosis
- B. Arteriosclerosis
- C. Aneurysm
- D. Thrombosis
Correct answer: A
Rationale: Atherosclerosis is the correct answer. It refers to the buildup of fatty deposits (plaque) along the inner walls of arteries, narrowing the blood vessels and reducing blood flow. This condition can lead to serious complications such as heart attacks or strokes. Arteriosclerosis (choice B) is a broader term that refers to the thickening and hardening of the arterial walls. While related, it is not as specific as atherosclerosis in describing the fatty deposit accumulation. Aneurysm (choice C) is the abnormal bulging of an artery wall that can rupture and cause internal bleeding, not specifically related to fatty deposits. Thrombosis (choice D) is the formation of a blood clot within a blood vessel, which can obstruct blood flow, but it is not directly related to the accumulation of fatty deposits.
3. Which condition is characterized by the weakening and rupture of the walls of the alveoli in the lungs, reducing the surface area available for gas exchange?
- A. Emphysema
- B. Bronchitis
- C. Atelectasis
- D. Pulmonary fibrosis
Correct answer: A
Rationale: The correct answer is A, Emphysema. Emphysema is a lung condition where the walls of the alveoli become weak and rupture, reducing the surface area available for gas exchange. This leads to shortness of breath. Choice B, Bronchitis, is characterized by inflammation of the bronchial tubes, not the alveoli. Choice C, Atelectasis, involves the collapse of a part or entire lung, not the weakening and rupture of alveolar walls. Choice D, Pulmonary fibrosis, is a condition where lung tissue becomes thickened and stiff, not involving the weakening and rupture of alveoli walls.
4. Which of the following is a type of heart valve disease where the aortic valve becomes narrowed, restricting blood flow from the heart to the rest of the body?
- A. Aortic stenosis
- B. Mitral stenosis
- C. Tricuspid regurgitation
- D. Pulmonary hypertension
Correct answer: A
Rationale: The correct answer is Aortic stenosis. In aortic stenosis, the aortic valve becomes narrowed, which obstructs the blood flow from the heart to the rest of the body. This condition can lead to symptoms like chest pain, shortness of breath, and fainting. Mitral stenosis (choice B) involves narrowing of the mitral valve, not the aortic valve. Tricuspid regurgitation (choice C) is a condition where the tricuspid valve leaks, causing blood to flow backward in the heart. Pulmonary hypertension (choice D) is high blood pressure in the arteries of the lungs.
5. The client is on spironolactone (Aldactone) and has a potassium level of 5.9 mEq/L. What is the nurse’s priority action?
- A. Hold the spironolactone and notify the healthcare provider.
- B. Administer potassium supplements.
- C. Continue the spironolactone as ordered.
- D. Increase the dose of spironolactone.
Correct answer: A
Rationale: The correct answer is A: Hold the spironolactone and notify the healthcare provider. A potassium level of 5.9 mEq/L is high, indicating hyperkalemia. Spironolactone is a potassium-sparing diuretic that can further increase potassium levels. Therefore, the priority action is to hold the medication to prevent exacerbating hyperkalemia and notify the healthcare provider for further guidance. Choice B is incorrect because administering potassium supplements would worsen hyperkalemia. Choice C is incorrect because continuing spironolactone could lead to a further increase in potassium levels. Choice D is incorrect because increasing the dose of spironolactone would exacerbate the hyperkalemia.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access